approval
saveEVRYSDI (RISDIPLAM) — FDA approval
community read0 votes
Sponsor: GENENTECH INC. Form: FOR SOLUTION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalEVRYSDI (RISDIPLAM) — FDA approvalFeb 10, 2026 · 234d ago
- approvalEVRYSDI (RISDIPLAM) — FDA approvalFeb 10, 2026 · 234d ago
- approvalEVRYSDI (RISDIPLAM) — FDA approvalJan 21, 2026 · 254d ago
- approvalEVRYSDI (RISDIPLAM) — FDA approvalJan 21, 2026 · 254d ago
- approvalEVRYSDI (RISDIPLAM) — FDA approvalJan 21, 2026 · 254d ago
- approvalEVRYSDI (RISDIPLAM) — FDA approvalFeb 11, 2025 · 598d ago
- approvalEVRYSDI (RISDIPLAM) — FDA approvalFeb 11, 2025 · 598d ago
- approvalEVRYSDI (RISDIPLAM) — FDA approvalSep 17, 2024 · 745d ago
same company · ±60 days · 4
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalJul 30, 2020
- approvalpolatuzumab vedotin: POLIVY (POLATUZUMAB VEDOTIN-PIIQ) — FDA approvalSep 18, 2020
- approvaltrastuzumab emtansine: KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalSep 27, 2020
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalSep 30, 2020
comments(0)
5-min edit window · permanent after that